Sandbox:tavr: Difference between revisions
No edit summary |
No edit summary |
||
Line 32: | Line 32: | ||
The most important step is to define the severity of AS and appropriate patient that need TAVR. | The most important step is to define the severity of AS and appropriate patient that need TAVR. | ||
Severe sypmtomatic (Stage D) AS is considered as TAVR candidate. | Severe sypmtomatic (Stage D) AS is considered as TAVR candidate. | ||
{| class="wikitable" | |||
! colspan="6" |Severe symptomatic AS (stage D) | |||
|- | |||
!STAGE | |||
!DEFINITION | |||
!SYMPTOMS | |||
!VALVE ANATOMY | |||
!VALVE HEMODYNAMICS | |||
!HEMODYNAMIC CONSEQUENCES | |||
|- | |||
|D1 | |||
|Symptomatic severe high-gradient [[Aortic stenosis|AS]] | |||
| | |||
* Exertional [[dyspnea]] or decreased exercise tolerance | |||
* Exertional [[angina]] | |||
* Exertional [[syncope]] or presyncope | |||
|Severe calcification or congenital stenosis with severely reduced opening | |||
| | |||
* Vmax ≥ 4 m/s or mean ΔP ≥ 40 mmHg | |||
* AVA ≤ 1.0 cm² but may be larger with mixed [[Aortic stenosis|AS]] and [[AR]] | |||
| | |||
* LV [[diastolic dysfunction]] | |||
* [[Left ventricular hypertrophy]] | |||
* May present with [[pulmonary hypertension]] | |||
|- | |||
|D2 | |||
|Symptomatic severe low-flow/low gradient AS with reduced [[LVEF]] | |||
| | |||
* [[Heart failure]] | |||
* [[Angina]] | |||
* [[Syncope]] or presyncope | |||
|Severe calcification or congenital stenosis with severely reduced leaflet motion | |||
| | |||
* AVA ≤ 1.0 cm² with resting aortic Vmax < 4 m/s or mean ΔP ≥ 40 mmHg | |||
* Dobutamine stress echo shows AVA ≤ 1.0 cm² with Vmax ≥ 4 m/s at any flow rate | |||
| | |||
* LV diastolic dysfunction | |||
* [[Left ventricular hypertrophy]] | |||
* [[LVEF]] <50% | |||
|- | |||
|D3 | |||
|Symptomatic severe low gradient with normal [[LVEF]] | |||
| | |||
* [[Heart failure]] | |||
* [[Angina]] | |||
* [[Syncope]] or presyncope | |||
|Severe calcification with severely reduced leaflet motion | |||
| | |||
* AVA ≤ 1.0 cm² with Vmax < 4 m/s or mean ΔP ≤ 40 mmHg | |||
* AVA ≤ 0.6 cm² | |||
* Stroke volume index < 35 mL/m² | |||
| | |||
* Increased LV relative wall thickness | |||
* Small LV chamber with low stroke volume | |||
* Restrictive diastolic filling | |||
* [[LVEF]] ≥ 50% | |||
|} |
Revision as of 19:15, 9 January 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Transcatheter Aortic Valve Replacement (TAVR) Procedure Guide Microchapters |
---|
Overview |
Causes |
FIRE |
Diagnosis |
Treatment |
Do's |
Don'ts |
Overview
During the past 50 years, surgical aortic valve replacement (SAVR) was the standard of care for patients with severe AS. Global aging has raised concerns about safety and possibility of surgical procedure in old patients with associated co-morbidities. Transcatheter aortic valve replacement (TAVR) created a new era of safety for this population and enabled physicians to replace the stenotic valve with more certainty.
Preoperation evaluation, selecting the appropriate imaging modality, issues in TAVR procedure and patient follow up are the areas of more focused importance.
We will describe these factors based on the recent expert consensus for TAVR procedure.
Definition
The most important step is to define the severity of AS and appropriate patient that need TAVR. Severe sypmtomatic (Stage D) AS is considered as TAVR candidate.
Severe symptomatic AS (stage D) | |||||
---|---|---|---|---|---|
STAGE | DEFINITION | SYMPTOMS | VALVE ANATOMY | VALVE HEMODYNAMICS | HEMODYNAMIC CONSEQUENCES |
D1 | Symptomatic severe high-gradient AS | Severe calcification or congenital stenosis with severely reduced opening |
| ||
D2 | Symptomatic severe low-flow/low gradient AS with reduced LVEF |
|
Severe calcification or congenital stenosis with severely reduced leaflet motion |
|
|
D3 | Symptomatic severe low gradient with normal LVEF |
|
Severe calcification with severely reduced leaflet motion |
|
|